Raloxifene and Sermorelin Interaction

Monitor
Mechanism-based 47% confidence

Raloxifene and Sermorelin have an interaction requiring monitoring for interaction with 47% confidence. Both Raloxifene and Sermorelin act on estrogen receptors. Receptor competition may reduce effectiveness of one or both. Using multiple SERMs simultaneously is generally not recommended — choose one. Both compounds affect the pituitary, so monitoring these systems is recommended.

Compound Profiles

Raloxifene

Selective Estrogen Receptor Modulator | Gynecomastia & Bone Health

Raloxifene binds to both estrogen receptor alpha (ERalpha) and estrogen receptor beta (ERbeta), producing tissue-dependent agonist or antagonist effects determined by the local complement of coactivator and corepressor proteins. In breast tissue, raloxifene functions as a potent estrogen antagonist, blocking estradiol-mediated proliferative signaling with high selectivity.

Half-life: ~28 hours Typical dose: 60mg oral daily pct
estrogen receptor hepatotoxicpct agentteratogenic
View full profile

Sermorelin

GHRH Analog | Growth Hormone Releasing Hormone

Subcutaneous injection provides optimal bioavailability for binding GHRH receptors, stimulating pulsatile GH release while maintaining hypothalamic-pituitary axis integrity and allowing natural somatostatin negative feedback..

Half-life: 10-12 minutes Typical dose: 200-300mcg per dose (up to 500mcg for athletic performance) growth hormone, weight loss
estrogen receptorghrh receptor carcinogenic riskinsulin disruptingteratogenic
View full profile

Combined Organ Load

Pituitary
low
Gonads
low
GI Tract
low

Shared Safety Flags

2x 2 compounds share the teratogenic safety flag (Raloxifene, Sermorelin). Monitor accordingly.

Frequently Asked Questions

Can I take Raloxifene with Sermorelin?

Yes, but with caution. Both Raloxifene and Sermorelin act on estrogen receptors. Receptor competition may reduce effectiveness of one or both. Using multiple SERMs simultaneously is generally not recommended — choose one. Regular monitoring is advised.

Is Raloxifene and Sermorelin safe together?

Based on pharmacological analysis, this combination is considered monitor. However, shared safety flags include: teratogenic. Monitor accordingly.

What are the interactions between Raloxifene and Sermorelin?

Both Raloxifene and Sermorelin act on estrogen receptors. Receptor competition may reduce effectiveness of one or both. Using multiple SERMs simultaneously is generally not recommended — choose one. This assessment has 47% confidence and is inferred from pharmacological mechanism analysis.

How should I time Raloxifene and Sermorelin?

Raloxifene has a half-life of ~28 hours and Sermorelin has a half-life of 10-12 minutes. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: Raloxifene vs Sermorelin

This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.